<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7157703\results\search\tropicalVirus\results.xml">
  <result pre="there are no licensed vaccines, such as Ebola, Lassa, or" exact="Zika" post="virus, have been witnessed [5,6,7]. Additionally, the emergence potential"/>
  <result pre="past LAVs, several LAV candidates targeting challenging pathogens such as" exact="Dengue" post="virus [40], Japanese Encephalitis virus [41], West Nile virus"/>
  <result pre="pathogens such as Dengue virus [40], Japanese Encephalitis virus [41]," exact="West Nile" post="virus [42], Zika virus [43], SARS [44], Malaria [45]"/>
  <result pre="virus [40], Japanese Encephalitis virus [41], West Nile virus [42]," exact="Zika" post="virus [43], SARS [44], Malaria [45] or Ebola virus"/>
  <result pre="including yellow fever, measles, polio, and influenza vaccines. Yellow Fever" exact="Yellow fever" post="(YF) is a serious hemorrhagic fever endemic to tropical"/>
  <result pre="Haemogogus, and Sabethes mosquito species [82]. The first isolations of" exact="YFV" post="were obtained through serial passage of the serum of"/>
  <result pre="in macaques and human cohorts and conferred protective immunity against" exact="YFV" post="[85]. This strain is known as YFV-17D and is"/>
  <result pre="is known as YFV-17D and is the basis of all" exact="YFV" post="vaccines used today [86]. Mass vaccination campaigns in Africa"/>
  <result pre="YF have increased [82]. The reason for the spread of" exact="YFV" post="to these areas is unknown, but could be the"/>
  <result pre="of increased human activity in ecosystems where sylvatic cycles of" exact="YFV" post="transmission occur, or due to a widening range of"/>
  <result pre="YFV-17D has a stronger resistance to mutations, and suggested that" exact="YFV" post="attenuation could be related to a higher fidelity of"/>
  <result pre="pathogens such as MV, YFV, dengue virus, Ebola virus or" exact="Zika" post="virus adds an additional layer of limitations to conventional"/>
  <result pre="live-attenuated Venezuelan equine encephalitis virus [222], YFV-17D [151] or live-attenuated" exact="Zika" post="virus [43]. NHP models for LAV research, however, present"/>
  <result pre="a useful system to investigate the replication dynamics of the" exact="Dengue" post="virus (DENV) in vivo, as well as anti-DENV adaptive"/>
  <result pre="immunogenicity, and efficacyJ. Virol.200478124971250710.1128/JVI.78.22.12497-12507.200415507637 43.ShanC.MuruatoA.E.JaggerB.W.RichnerJ.NunesB.T.D.MedeirosD.B.A.XieX.P.NunesJ.G.C.MorabitoK.M.KongW.P.et al.A single-dose live-attenuated vaccine prevents" exact="Zika" post="virus pregnancy transmission and testis damageNat. Commun.2017867610.1038/s41467-017-00737-828939807 44.EscriouN.CallendretB.LorinV.CombredetC.MarianneauP.FevrierM.TangyF.Protection from"/>
  <result pre="&amp;gt;99.7% (RD1 deletion from M. bovis) [129,130] [175,176,177] Mouse [146,193]" exact="Yellow fever" post="virus (YFV) Attenuation of causative pathogen 1937 [32] 99.37%"/>
 </snippets>
</snippetsTree>
